Adynamic Bone Disease Begins before Dialysis The 25 th Annual Dialysis Conference in Tampa Akihide Tokumoto, M.D. San-in Rosai Hospital, Yonago, Japan.

Slides:



Advertisements
Similar presentations
What Are We Referring to When We State PTH Level?.
Advertisements

LINEE GUIDA, KDIGO E DIALISI PERITONEALE
MINERAL AND BONE DISORDERS IN CHRONIC KIDNEY DISEASE PEDRAM.AHMADPOOR SHAHID BEHESHTI MEDICAL UNIVERSITY.
Chronic Kidney Disease-Related Mineral and Bone Disorder: Public Health Problem Kerry Willis PhD National Kidney Foundation.
Uncontrolled secondary hyperparathyroidism in a haemodialysis patient Jordi Bover, MD, PhD Fundació Puigvert Barcelona, Spain © Springer Healthcare, a.
CKD in individuals with CKD
ESRD Registry Committee, Korean Society of Nephrology*
Update of Anemia management in chronic kidney disease What is still missing.
Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis Presented by Mike Touchy, HO-I.
EDWARD WELSH MARCH Dialysis Adequacy (?).
Chronic Renal Failure Niroj Obeyesekere 3 rd year student notes.
Calcium & phosphor disturbance CKD- MBD Dr. Atapour.
 Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease:
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD)
Mario Cozzolino, MD, PhD NUOVE ACQUISIZIONI NELLA TERAPIA DELL’IPERPARATIROIDISMO SECONDARIO IN DIALISI PERITONEALE XV CONVEGNO del Gruppo di Studio di.
Hyperparathyroidism in Chronic Kidney Disease 醫五 李政霆.
The mortality associated with body size and muscle mass, fat mass and abdominal obesity in patients receiving hemodialysis Date: 2012/12/21 實習生:余萍 指導老師:蕭佩珍營養師.
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
Nephrology Grand Rounds 5/13/08. Refractory Hyperparathyroidism Brad Weaver.
PARATHYROID HORMONE, HYPERPARATHYROIDISM CKD, & PTH ASSAYS David Plaut & Shanti Narayanan Summer, 2012.
Chronic Kidney Disease
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Effect of cinacalcet on bone markers in a maintenance haemodialysis patient Solenn Pelletier, MD and Denis Fouque, MD, PhD Hôpital E. Herriot Lyon, France.
Bone and Mineral Disorders in Chronic Kidney Disease
Chronic Kidney Disease-Mineral and Bone Disorder
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
AfterBefore PTH pg/ml PTH pg/ml AfterBefore Case Report 1) Age 53, 17 yrs HIV infection TDF/FTC/EFZ Baseline 25(OH)D.
Taipei Medical University The Effect of Gender and Age on Nutritional Status of Hemodialysis Patients I ntroduction O bjective The prevalence of malnutrition.
NATIONAL KIDNEY AND TRANSPLANT INSTITUTE
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
Primary Article Rachel Knepp (Article 1) Pecovnik-Balon, B., Jakopin, E., Bevc, S., Knehtl, M., & Gorenjak, M. (2009). Vitamin D as a novel nontraditional.
Al wakeel J, Bayoumi M, Al Ghonaim M, Al Harbi A, Al Swaida A, Mashraqy A.
Biochemical Test Serum Calcium
Intelligent Database Systems Lab 國立雲林科技大學 National Yunlin University of Science and Technology 1 Predicting survival time for kidney dialysis patients:
Renal Osteodystrophy ( paraclinical evaluation ) Dr. Y. Ataipour Hashemi Nejad Hospital TUMS.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Changes in ESRD Medicare Reimbursement: What The Patient Needs to Know Jay Wish, MD Medical Director, Dialysis Program University Hospitals Case Medical.
Vitamin D deficiency and anemia in early chronic kidney disease 2010/05/18 R4 이완수 2010.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
RELATIONSHIP BETWEEN PARATHYROID HORMONE, VITAMIN-D, CALCIUM AND PHOSPHORUS IN CKD Neeraja Kunireddy, Priscilla Abraham Chandran, Sree Bhushan Raju, M.Noorjahan.
Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis :A randomized clinical trial Jay.
CKD Treatment 순천향 대학교병원 신장내과 R3 김재연. Chronic kidney disease (CKD) encompasses a spectrum of different pathophysiologic processes associated with abnormal.
What we are missing 2012 KDIGO guideline. Anemia.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Oral Phosphate Binders in Patients with Kidney Failure
3Neonatology, University of Miami, Miami, FL, USA
Evaluating the Effectiveness of Social Work Interventions:
When Using DOPPS Slides
Figure 5. Liver-fatty acid binding protein concentration in human serum. The serum L-FABP levels of the healthy control group (n=63), renal diseases of.
Sergey V. Veretennikov and Michael J. Campbell, MD
Department of Nephrology- Ain Shams University, Cairo, Egypt
The ECHO Observational Study
December 31st point prevalent counts by modality figure 3.1
Acute and Chronic Renal Failure
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Bone metabolism and disease in chronic kidney disease
Guidelines American Journal of Kidney Diseases
Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities
Volume 78, Pages S10-S21 (August 2010)
Volume 76, Pages S50-S99 (August 2009)
Volume 67, Issue 2, Pages (February 2005)
Volume 68, Issue 3, Pages (September 2005)
Volume 87, Issue 3, Pages (March 2015)
Volume 71, Issue 6, Pages (March 2007)
Volume 73, Issue 6, Pages (March 2008)
Volume 53, Issue 5, Pages (May 1998)
Volume 57, Issue 3, Pages (March 2000)
CKD Is a Global Burden With Major Implications
Presentation transcript:

Adynamic Bone Disease Begins before Dialysis The 25 th Annual Dialysis Conference in Tampa Akihide Tokumoto, M.D. San-in Rosai Hospital, Yonago, Japan

The prevalence of adynamic bone disease (ABD) has risen alarmingly, especially in the treatment of 2nd HPT by use of Vitamin D agents. On the other hand, the natural occurrence of ABD in the progression of ESRD exists without therapeutic intervention. We investigated the characteristics of ABD with bone biopsies performed at initiation of dialysis in order to gain an insight into the prevalence of ABD in the pre-dialysis stage. Aims 2 nd HPT ABD Vitamin D over-treatment Trade-off hypothesis Skeletal resistance of PTH BMP-7 deficiency ? progression of ESRD

From March 1996 to May 2004, 171 dialysis patients (pts) were evaluated with bone histology. 41 pts had received long-term dialysis and 130 pts were biopsied 1 month after start of maintenance dialysis. The last group of pts made up 60% of the total pts who entered maintenance dialysis in the same period. Dialysis modalities were 130 pts on hemodialysis and 41 pts on peritoneal dialysis. Dialysate calcium was 3.0 mEq/l in hemodialysis and 3.5 mEq/l in peritoneal dialysis. Vitamin D and Ca containing phosphate binder were given in 19 and 26 pts on long-term dialysis and 1and 1 pt at the initiation of dialysis, respectively. Within one week of bone biopsy, blood specimens were drawn to determine serum calcium, intact PTH using the Nichols IRMA (the Nichols Advantage intact PTH assay was NOT used), bone alkaline phosphatase (BAP, Metra Biosystems), and Osteocalcin (Mitsubishi, Japan). Bone specimens were obtained at the iliac crest vertically. The histological examination was performed by Dr. Takahashi of the Niigata Bone Science Institute in Japan and histological subtypes were defined according to the classification by Dr. Sherrard (Kidney Int 43: ,1993). Methods Fb.V/TVOV/BVBFR/BV adynamic bone (ABD)<0.5%<15%<3.9%/y mild lesion (ML)<0.5%<15%>3.9%/y osteitis fibrosa (OF)>0.5%<15%- mixed type (Mix)>0.5%>15%- osteomalacia (OM)<0.5%>15%- Subjects

At initiation of dialysis (n=130) On maintenance dialysis (n=41) OM Mix OF ML ABD Approximately the Same Distribution of Histological Subtypes of Renal Osteodystrophy at Initiation of & After Long Term Dialysis Results

Chronic glomerulonephritisDiabetes mellitus In the chronic glomerulonephritis group, bone turnover was prone to decrease over the course of maintenance dialysis. initiation of dialysis (n=43) maintenance dialysis (6) initiation of dialysis (n=55) maintenance dialysis (30) Mix ML ABD OF OM OF OM intact PTH (pg/ml) median Inter quartile range

Bone metabolic markers of ABD were not significantly different from those of mild lesion. Total (n=130) ABD (37) ML (60) OF (22) Mix (8) OM (3) Age, years61±1465±1362±1157±1850±1767±4 M/F83/4726/1140/209/136/22/1 Diabetes pts33(28%)17 (46%)21 (35%)3 (15%)0 (0%)2 (67%) HD/PD96/3429/843/1715/76/23/0 Ca, mg/dl9.0± ±0.78.8±0.88.1±0.78.4±0.5 iPTH, pg/ml302±243230±176241±144443±234 b 728±515 b 240±92 BAP, U/l 43±90 (n=88) 29±17 (29) 31±1 (35) 39±20 (14) 167±307 b (7) 51±28 (3) OC, ng/,ml 47±39 (n=95) 29±25 (27) 40±24 (43) 66±35 a (19) 125±107 b (4) 85 (1) a P <0.05 vs. ABD b P <0.01 vs. ABD by Scheffe post hoc test Patient demographics and biochemical profiles according to histological subtypes of renal osteodystrophy at initiation of dialysis

At initiation of dialysis On maintenance dialysis Pts with ABD at initiation of dialysis presented with lower serum calcium levels than those pts with ABD who were on long-term maintenance dialysis. * [ * [ ** [ * * * p <0.001 * p <0.05 (Mann-Whitney test) Ca, mg/dl

At initiation of dialysis On maintenance dialysis Pts with ABD at initiation of dialysis presented with higher serum intact PTH levels than those pts with ABD who were on long-term maintenance dialysis. * [ Intact PTH, pg/ml * P <0.05 (Mann-Whitney test)

ABD patient demographics and biochemical profiles at initiation of dialysis versus long-term maintenance dialysis At initiation of dialysis (n=37) On maintenance dialysis (14) p value (Mann-Whitney or Chi-square test) Age, years65±1357±13ns M/F26/119/5ns Duration, months1±0115±61<0.01 DM17(46%)2 (12%)<0.05 HD/PD29/810/4ns Vitamin D therapy04<0.01 Ca containing P binder15<0.01 Ca, mg/dl9.0± ±1.0 <0.01 iPTH, pg/ml median (interquartile range) 230± ( ) 234± ( ) <0.05 BAP, U/l29±18 (n=29) 26±10 (n=6) ns OC, ng/,ml30±23 (n=22)47±67 (n=10)ns Pts with ABD at initiation of dialysis presented with relatively lower calcium and higher intact PTH than those pts who were on long-term maintenance dialysis.

Morphometric parameters of ABD at initiation of versus long-term maintenance dialysis At initiation of dialysis (n=37) On maintenance dialysis (14) p value BV/TV, % 20±5 23±8ns ES/BS, % 21±11 10± OV/BV, % 5.3± ± N.Oc/BS, /mm 1.9± ± Ob.S/BS, % 3.5±6.93.4±4.4 ns Fb.V/BV, % 0.24± ± BFR/BV, %/yr 0.7±1.21.0±1.1 ns Comparing ABD in pts at initiation of dialysis versus ABD in pts on the long-term maintenance dialysis revealed that pts at initiation of dialysis had increased bone resorption with accumulation of osteoid and marrow fibrosis.

The Distribution of Intact PTH for Histological Subtypes of Renal Osteodystrophy <150150~300>300 ABD10216 ML OF1615 Mix026 OM021 In only 42% (55/130) of pts at start of dialysis and 51% (21/41) of pts on long- term maintenance dialysis the bone turnover status was accurately diagnosed by the level of serum intact PTH using the current K/DOQI guideline. <150150~300>300 ABD932 ML983 OF013 Mix011 OM011 At initiation of dialysisOn maintenance dialysis 10/37 =27% =Accuracy for intact PTH to diagnose ABD for pts at initiation of dialysis 9/14 =64% =Accuracy for intact PTH to diagnose ABD for pts on long-term dialysis

Area Under Curve (AUC) of ROC Curves for PTH Parameters and Bone Metabolic Markers to Diagnosis of Adynamic Bone From the study of 23 pts biopsied at initiation of dialysis Ratio CAP Intact PTH - CAP CAPOCBAPIntact PTH

From the study of 23 patients biopsied at start of dialysis Youden Index of Whole PTH for the Diagnosis of Low Turnover Bone Scantibodies Whole PTH, pg/ml (CAP)

From the result of 38 bone biopsies in our facilities (Japan) and Beth Israel Medical Center (Dr. Amerling, New York) Cut-off Values of PTH parameters to Predict Bone Turnover Status Whole PTH LowNormalHigh pg/ml Total PTH LowNormalHigh pg/ml Ratio LowNormalHigh

Almost the same prevalence of ABD was found at initiation of dialysis versus long-term maintenance dialysis. ABD patients presented at initiation of dialysis with relatively lower calcium and higher intact PTH compared to those on long-term maintenance dialysis. It was difficult to diagnose ABD by conventional bone metabolic markers at the initiation of dialysis. Whole PTH (CAP) and Whole PTH/7-84 PTH ratio were more accurate in identifying ABD at initiation of dialysis. Conclusions